Skip to main content
Top
Published in: Maternal and Child Health Journal 1/2006

Open Access 01-09-2006 | Original Paper

Preconception Care for Improving Perinatal Outcomes: The Time to Act

Authors: Hani K. Atrash, Kay Johnson, Myron (Mike) Adams, José F. Cordero, Jennifer Howse

Published in: Maternal and Child Health Journal | Special Issue 1/2006

Login to get access

Excerpt

A healthy baby and a healthy mother are valued hopes and dreams of families of all cultural heritages. National health goals in many countries around the world prioritize infant and maternal mortality and morbidity. In the United States, as in many other industrialized countries, pregnancy outcomes and maternal and infant health indicators have improved dramatically. At the turn of the 20th century, 7.28 women and 96 infants died for every 1,000 babies born alive [1]. By the end of the year 2000, the maternal mortality rate had decreased to less than 0.08 and infant mortality had decreased to less than 7 deaths per 1,000 live births [2]. These changes were characterized as one of the ten “great public health achievements” of the 20th century [3]. Much of this progress can be attributed to changes in social and living conditions as well as the development and implementation of effective medical interventions. Despite this progress, during the last two decades of the 20th century, even in the presence of significant breakthroughs in medical technology and its application, improvements in maternal and infant pregnancy ouctomes slowed down significantly, and in some cases, outcomes deteriorated. For example, from 1960 to 1980, the maternal mortality rate decreased from 32.1 to 9.4 deaths per 100,000 live births, a decrease of 70.7%. From 1980 to 2000, the maternal mortality rate decreased only 12.8%, from 9.4 to 8.2 (Figure 1) [2]. At the same time, from 1980 to 2000, the proportion of babies born preterm, very preterm, low birth weight, and very low birth weight increased by 26%, 8.2%, 14.7% and 25.9%, respectively (Figure 2) [4]. However, unlike other maternal and infant health indicators, from 1980 to 2000 the infant mortality rate continued to decrease almost at a similar pace as that from 1960 to 1980, dropping by 45.2% from 12.6 to 6.9 infant deaths per 1,000 live births, compared with a drop of 51.5% from 26.0 to 12.6 per 1,000 live births for 1960 to 1980 (Figure 1) [2]. Finally, it is estimated that the proportion of babies born in the United States who have a serious or major structural defect that can have adverse effects on their health or development continues to be about 3% [5]. …
Literature
1.
go back to reference United States Department of Health, Education, and Welfare. Infant, fetal, and maternal mortality: United States—1963. Washington, DC: The Department; 1966. United States Department of Health, Education, and Welfare. Infant, fetal, and maternal mortality: United States—1963. Washington, DC: The Department; 1966.
2.
go back to reference United States Department of Health and Human Services. Health United States, 2004. Hyattsville, MD: The Department; 2004. United States Department of Health and Human Services. Health United States, 2004. Hyattsville, MD: The Department; 2004.
3.
go back to reference Centers for Disease Control and Prevention. Healthier mothers and babies. MMWR 1999;48:849–58. Centers for Disease Control and Prevention. Healthier mothers and babies. MMWR 1999;48:849–58.
4.
go back to reference Centers for Disease Control and Prevention. Birth: final data for 2002. National Vital Statistics Reports 2003;52. Centers for Disease Control and Prevention. Birth: final data for 2002. National Vital Statistics Reports 2003;52.
5.
go back to reference Correa-Villasenor A, et al. The Metropolitan Atlanta Congenital Defects Program: 35 years of birth defects surveillance at the Centers for Disease Control and Prevention. Birth Defects Res 2003;67:617–24.CrossRef Correa-Villasenor A, et al. The Metropolitan Atlanta Congenital Defects Program: 35 years of birth defects surveillance at the Centers for Disease Control and Prevention. Birth Defects Res 2003;67:617–24.CrossRef
6.
go back to reference Centers for Disease Control and Prevention. Advance report of final mortality statistics, 1980. Monthly Vital Statistics Report 1983;32 Suppl. Centers for Disease Control and Prevention. Advance report of final mortality statistics, 1980. Monthly Vital Statistics Report 1983;32 Suppl.
7.
go back to reference Centers for Disease Control and Prevention. Deaths: leading causes for 2002. National Vital Statistics Reports 2005;53. Centers for Disease Control and Prevention. Deaths: leading causes for 2002. National Vital Statistics Reports 2005;53.
8.
go back to reference Danel I, et al. Magnitude of maternal morbidity during labor and delivery: United States, 1993–1997. Am J Public Health 2003;93:631–4.PubMedCrossRef Danel I, et al. Magnitude of maternal morbidity during labor and delivery: United States, 1993–1997. Am J Public Health 2003;93:631–4.PubMedCrossRef
9.
go back to reference United States Department of Health and Human Services, Health Resources and Services Administration, Maternal and Child Health Bureau. Women's health USA 2002. Rockville, MD: The Department; 2004. United States Department of Health and Human Services, Health Resources and Services Administration, Maternal and Child Health Bureau. Women's health USA 2002. Rockville, MD: The Department; 2004.
10.
go back to reference Centers for Disease Control and Prevention. Alcohol consumption among women who are pregnant or who might become pregnant—United States, 2002. MMWR 2004;53:1178 Centers for Disease Control and Prevention. Alcohol consumption among women who are pregnant or who might become pregnant—United States, 2002. MMWR 2004;53:1178
11.
go back to reference Besculides M, Laraque F. Racial and ethnic disparities in perinatal mortality: applying the perinatal periods of risk model to identify areas for intervention. JAMA 2005;97:1128–32. Besculides M, Laraque F. Racial and ethnic disparities in perinatal mortality: applying the perinatal periods of risk model to identify areas for intervention. JAMA 2005;97:1128–32.
12.
go back to reference Cai J, Hoff GL, Dew PC, Guillory VJ, Manning J. Perinatal periods of risk: analysis of fetal-infant mortality rates in Kansas City, Missouri. Matern Child Health J 2005;9:199–205.PubMedCrossRef Cai J, Hoff GL, Dew PC, Guillory VJ, Manning J. Perinatal periods of risk: analysis of fetal-infant mortality rates in Kansas City, Missouri. Matern Child Health J 2005;9:199–205.PubMedCrossRef
13.
go back to reference Burns PG. Reducing infant mortality rates using the perinatal periods of risk model. Public Health Nurs 2005;22:2–7.PubMedCrossRef Burns PG. Reducing infant mortality rates using the perinatal periods of risk model. Public Health Nurs 2005;22:2–7.PubMedCrossRef
14.
go back to reference March of Dimes Birth Defects Foundation. March of Dimes Updates: Is early prenatal care too late? Contemp Ob/Gyn 2002;12:54–72. March of Dimes Birth Defects Foundation. March of Dimes Updates: Is early prenatal care too late? Contemp Ob/Gyn 2002;12:54–72.
15.
go back to reference American Academy of Pediatrics and the American College of Obstetricians and Gynecologists. In: Gilstrap L, Oh W, editors. Guidelines for perinatal care. 5th ed. Washington, DC, 2002. American Academy of Pediatrics and the American College of Obstetricians and Gynecologists. In: Gilstrap L, Oh W, editors. Guidelines for perinatal care. 5th ed. Washington, DC, 2002.
16.
go back to reference Korenbrot CC, et al. Preconception care: A systematic review. Mater Child Health J 2002;6:75–88.CrossRef Korenbrot CC, et al. Preconception care: A systematic review. Mater Child Health J 2002;6:75–88.CrossRef
17.
go back to reference United States Public Health Service. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR 1992;41(RR14). United States Public Health Service. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR 1992;41(RR14).
18.
go back to reference Centers for Disease Control and Prevention. Effectiveness in disease and injury prevention use of folic acid for prevention of spina bifida and other neural tube defects—1983–1991. MMWR 1991;40:513–6. Centers for Disease Control and Prevention. Effectiveness in disease and injury prevention use of folic acid for prevention of spina bifida and other neural tube defects—1983–1991. MMWR 1991;40:513–6.
19.
go back to reference United States Preventive Services Task Force. Screening for neural tube defects. Guide to clinical preventive services. 2nd ed. 1996, pp. 473–6. United States Preventive Services Task Force. Screening for neural tube defects. Guide to clinical preventive services. 2nd ed. 1996, pp. 473–6.
20.
go back to reference American College of Obstetricians and Gynecologists. Clinical management guidelines for obstetrician-gynecologists. Committee Opinion No. 44 (replaces Committee Opinion No. 252, March 2001). Obstet Gynecol 2003;102:203–13.CrossRef American College of Obstetricians and Gynecologists. Clinical management guidelines for obstetrician-gynecologists. Committee Opinion No. 44 (replaces Committee Opinion No. 252, March 2001). Obstet Gynecol 2003;102:203–13.CrossRef
21.
go back to reference American College of Obstetricians and Gynecologists Committee on Obstetrics: Maternal and Fetal Medicine. Folic acid for the prevention of recurrent neural tube defects. Committee Opinion No. 120, March 1993. Int J Gynaecol Obstet 1993;42:75–7.CrossRef American College of Obstetricians and Gynecologists Committee on Obstetrics: Maternal and Fetal Medicine. Folic acid for the prevention of recurrent neural tube defects. Committee Opinion No. 120, March 1993. Int J Gynaecol Obstet 1993;42:75–7.CrossRef
22.
go back to reference Institute of Medicine Food and Nutrition Board. Dietary reference intakes for folate and other B vitamins. Washington, DC: National Academies Press; 1998. Institute of Medicine Food and Nutrition Board. Dietary reference intakes for folate and other B vitamins. Washington, DC: National Academies Press; 1998.
23.
go back to reference Institute of Medicine Food and Nutrition Board. Dietary reference intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic acid, Biotin, and Choline. Washington, DC: National Academies Press; 2000. Institute of Medicine Food and Nutrition Board. Dietary reference intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic acid, Biotin, and Choline. Washington, DC: National Academies Press; 2000.
24.
go back to reference Lumley J, et al. Periconceptional supplementation with folate and(or multivitamins for preventing neural tube defects. Cochrane Database Syst Rev 2001;CD001056. Lumley J, et al. Periconceptional supplementation with folate and(or multivitamins for preventing neural tube defects. Cochrane Database Syst Rev 2001;CD001056.
25.
go back to reference Centers for Disease Control and Prevention. Control and prevention of rubella: evaluation and management of suspected outbreaks, rubella in pregnant women, and surveillance for congenital rubella syndrome. MMWR 2001;50(RR12). Centers for Disease Control and Prevention. Control and prevention of rubella: evaluation and management of suspected outbreaks, rubella in pregnant women, and surveillance for congenital rubella syndrome. MMWR 2001;50(RR12).
26.
go back to reference United States Preventive Services Task Force. Screening for rubella. Guide to clinical preventive services. 2nd ed. 1996. United States Preventive Services Task Force. Screening for rubella. Guide to clinical preventive services. 2nd ed. 1996.
27.
go back to reference American College of Obstetricians and Gynecologists. Rubella vaccination. Committee opinion no. 281, December 2002. Int J Gynaecol Obstet 2003;81:241.CrossRef American College of Obstetricians and Gynecologists. Rubella vaccination. Committee opinion no. 281, December 2002. Int J Gynaecol Obstet 2003;81:241.CrossRef
28.
go back to reference American Diabetes Association. Preconceptional care of women with diabetes. Diabetes Care 2004;27 Suppl:S76–8. American Diabetes Association. Preconceptional care of women with diabetes. Diabetes Care 2004;27 Suppl:S76–8.
29.
go back to reference Kitzmiller JL et al. Preconception care of diabetes, congenital malformations, and spontaneous abortions (technical review). Diabetes Care 1996;19:514–41.PubMed Kitzmiller JL et al. Preconception care of diabetes, congenital malformations, and spontaneous abortions (technical review). Diabetes Care 1996;19:514–41.PubMed
30.
go back to reference American College of Obstetricians and Gynecologists Committee on Technical Bulletins. Diabetes and pregnancy. Technical Bulletin No. 200, December 1994 (replaces No. 92, May 1986). Int J Gynaecol Obstet 1995;48:31–9.CrossRef American College of Obstetricians and Gynecologists Committee on Technical Bulletins. Diabetes and pregnancy. Technical Bulletin No. 200, December 1994 (replaces No. 92, May 1986). Int J Gynaecol Obstet 1995;48:31–9.CrossRef
31.
go back to reference Centers for Disease Control and Prevention. Strategies for reducing morbidity and mortality from diabetes through health-care system interventions and diabetes self-management education in community settings. MMWR 2001;50(RR16). Centers for Disease Control and Prevention. Strategies for reducing morbidity and mortality from diabetes through health-care system interventions and diabetes self-management education in community settings. MMWR 2001;50(RR16).
32.
go back to reference Helfand M, United States Preventive Services Task Force. Screening for subclinical thyroid dysfunction in nonpregnant adults: a summary of the evidence for the United States Preventive Services Task Force. Ann Intern Med 2004;40:128–41. Helfand M, United States Preventive Services Task Force. Screening for subclinical thyroid dysfunction in nonpregnant adults: a summary of the evidence for the United States Preventive Services Task Force. Ann Intern Med 2004;40:128–41.
33.
go back to reference American College of Obstetricians and Gynecologists. Thyroid disease in pregnancy. Clinical management guidelines for Obstetrician-Gynecologists. Practice bulletin no. 37, August 2002. Obstet Gynecol 2002;100:387–96.CrossRef American College of Obstetricians and Gynecologists. Thyroid disease in pregnancy. Clinical management guidelines for Obstetrician-Gynecologists. Practice bulletin no. 37, August 2002. Obstet Gynecol 2002;100:387–96.CrossRef
34.
go back to reference American Association of Clinical Endocrinologists, AACE Thyroid Task Force. Medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism. Endocr Prac 2002;8:457–69. American Association of Clinical Endocrinologists, AACE Thyroid Task Force. Medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism. Endocr Prac 2002;8:457–69.
35.
go back to reference Centers for Disease Control and Prevention. Revised guidelines for HIV counseling, testing, and referral. Revised recommendations for HIV screening of pregnant women. MMWR 2001;50(RR19). Centers for Disease Control and Prevention. Revised guidelines for HIV counseling, testing, and referral. Revised recommendations for HIV screening of pregnant women. MMWR 2001;50(RR19).
36.
go back to reference United States Public Health Service Task Force. Recommendations for use of antiretroviral drugs in pregnant HIV-1—infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States. MMWR 2002;51(RR18):1–38. United States Public Health Service Task Force. Recommendations for use of antiretroviral drugs in pregnant HIV-1—infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States. MMWR 2002;51(RR18):1–38.
37.
go back to reference American College of Obstetricians and Gynecologists. Human immunodeficiency virus infections in pregnancy. Int J Gynaecol Obstet 1997;57:73–80.CrossRef American College of Obstetricians and Gynecologists. Human immunodeficiency virus infections in pregnancy. Int J Gynaecol Obstet 1997;57:73–80.CrossRef
38.
go back to reference American College of Obstetricians and Gynecologists Committee on Ethics. Human immunodeficiency virus: ethical guidelines for obstetricians and gynecologists. Obstet Gynecol 2001;97 Suppl:1–6. American College of Obstetricians and Gynecologists Committee on Ethics. Human immunodeficiency virus: ethical guidelines for obstetricians and gynecologists. Obstet Gynecol 2001;97 Suppl:1–6.
39.
go back to reference Institute of Medicine. Reducing the odds: Preventing perinatal transmission of HIV in the United States. Washington, DC: National Academy Press; 1999. Institute of Medicine. Reducing the odds: Preventing perinatal transmission of HIV in the United States. Washington, DC: National Academy Press; 1999.
40.
go back to reference Institute of Medicine. Make prenatal HIV testing part of routine care. AIDS Alert 1998;13:137–8. Institute of Medicine. Make prenatal HIV testing part of routine care. AIDS Alert 1998;13:137–8.
41.
go back to reference Brocklehurst P, Volmink J. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. Cochrane Database Syst Rev 2002;CD003510. Brocklehurst P, Volmink J. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. Cochrane Database Syst Rev 2002;CD003510.
42.
go back to reference Phenylketonuria: Screening and Management. NIH Consensus Statement Online 2000 October 16-18:17, 1–27. Available at: URL: http://consensus.nih.gov/2000/2000Phenylketonuria113html.htm Phenylketonuria: Screening and Management. NIH Consensus Statement Online 2000 October 16-18:17, 1–27. Available at: URL: http://​consensus.​nih.​gov/​2000/​2000Phenylketonu​ria113html.​htm
43.
go back to reference American College of Obstetricians and Gynecologists Committee on Genetics. Maternal phenylketonuria. Int J Gynaecol Obstet 2001;72:83–4. American College of Obstetricians and Gynecologists Committee on Genetics. Maternal phenylketonuria. Int J Gynaecol Obstet 2001;72:83–4.
44.
go back to reference American College of Obstetricians and Gynecologists Committee on Practice Bulletins—Obstetrics. Thrombembolism in pregnancy. Int J Gynaecol Obstet 2001;75:203–12.CrossRef American College of Obstetricians and Gynecologists Committee on Practice Bulletins—Obstetrics. Thrombembolism in pregnancy. Int J Gynaecol Obstet 2001;75:203–12.CrossRef
45.
go back to reference American College of Obstetricians and Gynecologists. Preventing deep venous thrombosis and pulmonary embolism. Am Fam Physician 2001;63:2279–80. American College of Obstetricians and Gynecologists. Preventing deep venous thrombosis and pulmonary embolism. Am Fam Physician 2001;63:2279–80.
46.
go back to reference Hirsh J, et al. American Heart Association/American College of Cardiology Foundation guide to warfarin therapy. Circulation 2003;107:692–711.CrossRef Hirsh J, et al. American Heart Association/American College of Cardiology Foundation guide to warfarin therapy. Circulation 2003;107:692–711.CrossRef
47.
go back to reference American College of Obstetricians and Gynecologists. Seizure disorders in pregnancy Educational bulletin no. 231. Int J Gynec Obstet 1997;56:279–86.CrossRef American College of Obstetricians and Gynecologists. Seizure disorders in pregnancy Educational bulletin no. 231. Int J Gynec Obstet 1997;56:279–86.CrossRef
48.
go back to reference Barrett C, Richens A. Epilepsy and pregnancy: report of an Epilepsy Research Foundation Workshop. Epilepsy Res 2003;52:147–87.PubMedCrossRef Barrett C, Richens A. Epilepsy and pregnancy: report of an Epilepsy Research Foundation Workshop. Epilepsy Res 2003;52:147–87.PubMedCrossRef
49.
go back to reference Crawford P, et al. Best practice guidelines for the management of women with epilepsy. The Women with Epilepsy Guidelines Development Group. Seizure 1999;8:201–17.PubMedCrossRef Crawford P, et al. Best practice guidelines for the management of women with epilepsy. The Women with Epilepsy Guidelines Development Group. Seizure 1999;8:201–17.PubMedCrossRef
50.
go back to reference Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter: management issues for women with epilepsy (summary statement). Neurology 1998;51:944–8. Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter: management issues for women with epilepsy (summary statement). Neurology 1998;51:944–8.
51.
go back to reference Morrell MJ. Guidelines for the care of women with epilepsy—Consensus conference—Current clinical practice. Neurology 1998;51Suppl:S21–7.PubMed Morrell MJ. Guidelines for the care of women with epilepsy—Consensus conference—Current clinical practice. Neurology 1998;51Suppl:S21–7.PubMed
52.
go back to reference Centers for Disease Control and Prevention. Accutane-exposed pregnancies—California, 1999. MMWR 2000;49:28–31. Centers for Disease Control and Prevention. Accutane-exposed pregnancies—California, 1999. MMWR 2000;49:28–31.
53.
go back to reference Perlman SE, et al. Caring for women with childbearing potential taking teratogenic dermatologic drugs—guidelines for practice. J Reprod Med 2001;46Suppl:153–61.PubMed Perlman SE, et al. Caring for women with childbearing potential taking teratogenic dermatologic drugs—guidelines for practice. J Reprod Med 2001;46Suppl:153–61.PubMed
54.
go back to reference Perlman SE, et al. “Be smart, be safe, be sure.” The revised Pregnancy Prevention Program for women on isotretinoin. J Reprod Med 2001;46Suppl:179–85.PubMed Perlman SE, et al. “Be smart, be safe, be sure.” The revised Pregnancy Prevention Program for women on isotretinoin. J Reprod Med 2001;46Suppl:179–85.PubMed
55.
go back to reference United States Department of Health and Human Services, Public Health Service. Clinical Practice Guideline: Treating tobacco use and dependence. Washington, DC: The Department; 2000. United States Department of Health and Human Services, Public Health Service. Clinical Practice Guideline: Treating tobacco use and dependence. Washington, DC: The Department; 2000.
56.
go back to reference United States Preventive Services Task Force. Counseling: tobacco use Guide to Preventive Services, 3rd edition, Periodic Updates. Available at: URL: http://www.ahrq.gov/clinic/uspstf/uspstbac .htm United States Preventive Services Task Force. Counseling: tobacco use Guide to Preventive Services, 3rd edition, Periodic Updates. Available at: URL: http://​www.​ahrq.​gov/​clinic/​uspstf/​uspstbac .htm
57.
go back to reference Hopkins DP, et al. Task Force on Community Preventive Services. Reviews of evidence regarding interventions to reduce tobacco use and exposure to environmental tobacco smoke. Am J Prev Med 2001;20Suppl:16–66.PubMedCrossRef Hopkins DP, et al. Task Force on Community Preventive Services. Reviews of evidence regarding interventions to reduce tobacco use and exposure to environmental tobacco smoke. Am J Prev Med 2001;20Suppl:16–66.PubMedCrossRef
58.
go back to reference American College of Obstetricians and Gynecologists. Smoking cessation during pregnancy. Educational bulletin no. 260, September 2000. Int J Gynaecol Obstet 2001;75:345–8. American College of Obstetricians and Gynecologists. Smoking cessation during pregnancy. Educational bulletin no. 260, September 2000. Int J Gynaecol Obstet 2001;75:345–8.
59.
go back to reference Weber MK, et al. National Task Force on Fetal Alcohol Syndrome and Fetal Alcohol Effect. Defining the national agenda for fetal alcohol syndrome and other prenatal alcohol-related effects. MMWR 2002;51(RR14):9–12.PubMed Weber MK, et al. National Task Force on Fetal Alcohol Syndrome and Fetal Alcohol Effect. Defining the national agenda for fetal alcohol syndrome and other prenatal alcohol-related effects. MMWR 2002;51(RR14):9–12.PubMed
60.
go back to reference United States Preventive Services Task Force. Screening and behavioral counseling interventions in primary care to reduce alcohol misuse: recommendation statement. Ann Intern Med 2004;140:554–6. United States Preventive Services Task Force. Screening and behavioral counseling interventions in primary care to reduce alcohol misuse: recommendation statement. Ann Intern Med 2004;140:554–6.
61.
go back to reference Whitlock EP, et al. United States Preventive Services Task Force. Behavioral counseling interventions in primary care to reduce risky(harmful alcohol use by adults: a summary of the evidence for the United States Preventive Services Task Force. Ann Intern Med 2004;40:557–68. Whitlock EP, et al. United States Preventive Services Task Force. Behavioral counseling interventions in primary care to reduce risky(harmful alcohol use by adults: a summary of the evidence for the United States Preventive Services Task Force. Ann Intern Med 2004;40:557–68.
62.
go back to reference American College of Obstetricians and Gynecologists. Substance abuse in pregnancy. Technical Bulletin No. 195, July 1994 (replaces No. 96, September 1986). Int J Gynaecol Obstet 1994;47:73–80.CrossRef American College of Obstetricians and Gynecologists. Substance abuse in pregnancy. Technical Bulletin No. 195, July 1994 (replaces No. 96, September 1986). Int J Gynaecol Obstet 1994;47:73–80.CrossRef
63.
go back to reference Stratton K, Howe C, Battaglia FC, editors, Committee to Study Fetal Alcohol Syndrome. Institute of Medicine. Fetal Alcohol Syndrome: Diagnosis, epidemiology, prevention, and treatment. Washington, DC: National Academies Press; 1996. Stratton K, Howe C, Battaglia FC, editors, Committee to Study Fetal Alcohol Syndrome. Institute of Medicine. Fetal Alcohol Syndrome: Diagnosis, epidemiology, prevention, and treatment. Washington, DC: National Academies Press; 1996.
64.
go back to reference Bonnie RJ, O’Connell ME, editors; Committee on Developing a Strategy to Reduce and Prevent Underage Drinking. Institute of Medicine. Reducing Underage Drinking: A collective responsibility. Washington, DC: National Academies Press; 2004. Bonnie RJ, O’Connell ME, editors; Committee on Developing a Strategy to Reduce and Prevent Underage Drinking. Institute of Medicine. Reducing Underage Drinking: A collective responsibility. Washington, DC: National Academies Press; 2004.
65.
go back to reference United States Department of Health and Human Services, Public Health Service, National Institutes of Health, National Heart, Lung, and Blood Institute Obesity Education Initiative. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: The Evidence Report. Bethesda (MD): The Department, 1998. NIH Publication No. 98-4083. United States Department of Health and Human Services, Public Health Service, National Institutes of Health, National Heart, Lung, and Blood Institute Obesity Education Initiative. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: The Evidence Report. Bethesda (MD): The Department, 1998. NIH Publication No. 98-4083.
66.
go back to reference United States Preventive Services Task Force. Screening for obesity in adults: recommendations and rationale. Ann Intern Med 2003;139:930–2. United States Preventive Services Task Force. Screening for obesity in adults: recommendations and rationale. Ann Intern Med 2003;139:930–2.
67.
go back to reference Institute of Medicine. Subcommittee on nutritional status and weight gain during pregnancy. Washington, DC: National Academy Press; 1990. Institute of Medicine. Subcommittee on nutritional status and weight gain during pregnancy. Washington, DC: National Academy Press; 1990.
68.
go back to reference Kramer MS. Energy/protein restriction for high weight-for-height or weight gain during pregnancy. Cochrane Database Syst Rev 2000;CD000080. Kramer MS. Energy/protein restriction for high weight-for-height or weight gain during pregnancy. Cochrane Database Syst Rev 2000;CD000080.
69.
go back to reference American College of Preventive Medicine Practice. Policy statement: weight management counseling of overweight adults. Am J Prev Med 2001;21:73–8.CrossRef American College of Preventive Medicine Practice. Policy statement: weight management counseling of overweight adults. Am J Prev Med 2001;21:73–8.CrossRef
70.
go back to reference Centers for Disease Control and Prevention. Chlamydia trachomatis genital infections—United States, 1995. MMWR 1997;46:193–8. Centers for Disease Control and Prevention. Chlamydia trachomatis genital infections—United States, 1995. MMWR 1997;46:193–8.
71.
go back to reference Centers for Disease Control and Prevention. Gonorrhea—United States, 1998. MMWR 2000;49:538–42. Centers for Disease Control and Prevention. Gonorrhea—United States, 1998. MMWR 2000;49:538–42.
72.
go back to reference Centers for Disease Control and Prevention. Hepatitis B vaccination—United States, 1982–2002. MMWR 2002;51:549–52, 63. Centers for Disease Control and Prevention. Hepatitis B vaccination—United States, 1982–2002. MMWR 2002;51:549–52, 63.
73.
go back to reference Gunn RA, et al. Integrating hepatitis, STD, and HIV services into a drug rehabilitation program. Am J Prev Med 2005;29:27–33.PubMedCrossRef Gunn RA, et al. Integrating hepatitis, STD, and HIV services into a drug rehabilitation program. Am J Prev Med 2005;29:27–33.PubMedCrossRef
74.
go back to reference Centers for Disease Control and Prevention. A comprehensive immunization strategy to eliminate the transmission of hepatitis B virus infection in the United States. Recommendations of the Advisory Committee on Immunization Practices (ACIP) part I—immunization of infants, children, and adolescents. MMWR 2005;54(RR-16):1–23. Centers for Disease Control and Prevention. A comprehensive immunization strategy to eliminate the transmission of hepatitis B virus infection in the United States. Recommendations of the Advisory Committee on Immunization Practices (ACIP) part I—immunization of infants, children, and adolescents. MMWR 2005;54(RR-16):1–23.
75.
go back to reference Czeizel AE. Ten years of experience in periconceptional care. Eur J Obstet Gynecol Reprod Biol 1999;84:43–9.PubMedCrossRef Czeizel AE. Ten years of experience in periconceptional care. Eur J Obstet Gynecol Reprod Biol 1999;84:43–9.PubMedCrossRef
76.
go back to reference Moos MK. Preconceptional wellness as a routine objective for women's health care: An integrative strategy. J Obstet Gynecol Neonatal Nurs 2003;32:550–6.PubMedCrossRef Moos MK. Preconceptional wellness as a routine objective for women's health care: An integrative strategy. J Obstet Gynecol Neonatal Nurs 2003;32:550–6.PubMedCrossRef
77.
go back to reference Jack BW, et al. Addressing preconception risks identified at the time of a negative pregnancy test. A randomized trial. J Fam Pract 1998;47:33–8.PubMed Jack BW, et al. Addressing preconception risks identified at the time of a negative pregnancy test. A randomized trial. J Fam Pract 1998;47:33–8.PubMed
78.
go back to reference Rodgers BD, Rodgers DE. Efficacy of preconception care of diabetic women in a community setting. J Reprod Med 1996;41:422–6.PubMed Rodgers BD, Rodgers DE. Efficacy of preconception care of diabetic women in a community setting. J Reprod Med 1996;41:422–6.PubMed
79.
go back to reference Lomas J. Retailing Research: Increasing the role of evidence in clinical services for childbirth. Milbank Q 1993;71:439–76.PubMedCrossRef Lomas J. Retailing Research: Increasing the role of evidence in clinical services for childbirth. Milbank Q 1993;71:439–76.PubMedCrossRef
80.
go back to reference Barash JH, Weinstein LC. Preconception and prenatal care. Prim Care 2002;29:519–42.PubMed Barash JH, Weinstein LC. Preconception and prenatal care. Prim Care 2002;29:519–42.PubMed
81.
go back to reference Brundage SC. Preconception health care. Am Fam Physician 2002;65:2507–14.PubMed Brundage SC. Preconception health care. Am Fam Physician 2002;65:2507–14.PubMed
82.
go back to reference Henderson JT, et al. The role of physician gender in the evaluation of the National Centers of Excellence in Women's Health: test of an alternate hypothesis. Women's Health Issues 2004;14:130–9.PubMedCrossRef Henderson JT, et al. The role of physician gender in the evaluation of the National Centers of Excellence in Women's Health: test of an alternate hypothesis. Women's Health Issues 2004;14:130–9.PubMedCrossRef
83.
go back to reference Kaiser Family Foundation. Women and health care: Key findings from the women's health survey. Washington, DC: The Foundation; 2005. Kaiser Family Foundation. Women and health care: Key findings from the women's health survey. Washington, DC: The Foundation; 2005.
84.
go back to reference Kaiser Family Foundation. Women's Health Policy Fact Sheet: Women's Health Insurance Coverage, November 2004. Kaiser Family Foundation. Women's Health Policy Fact Sheet: Women's Health Insurance Coverage, November 2004.
85.
go back to reference Kaiser Family Foundation. Medicaid's Role for Women. Issue Brief on Women's Health Policy, November 2004. Kaiser Family Foundation. Medicaid's Role for Women. Issue Brief on Women's Health Policy, November 2004.
86.
go back to reference Edwards J, Bronstein J, Adams K. Evaluation of Medicaid Family Planning Demonstrations. The CAN Corporations Contract No. 752-2-415921. Sponsored by the Centers for Medicare and Medicaid Services, U.S. Department of Health and Human Services. Edwards J, Bronstein J, Adams K. Evaluation of Medicaid Family Planning Demonstrations. The CAN Corporations Contract No. 752-2-415921. Sponsored by the Centers for Medicare and Medicaid Services, U.S. Department of Health and Human Services.
87.
go back to reference National Association of State Medicaid Directors. Review of Medicaid Family Planning Expansion Waivers, 2004. Available at: URL: www.nasmd.org. National Association of State Medicaid Directors. Review of Medicaid Family Planning Expansion Waivers, 2004. Available at: URL: www.nasmd.org.
88.
go back to reference USPHS- US Public Health Service Expert Panel on the Content of Prenatal Care. Caring for Our Future: The Content of Prenatal Care. Washington, DC: US Dept of Health and Human Services, 1989. USPHS- US Public Health Service Expert Panel on the Content of Prenatal Care. Caring for Our Future: The Content of Prenatal Care. Washington, DC: US Dept of Health and Human Services, 1989.
89.
go back to reference Petrie K, Frey KA, editors. Preconception Care/Infertility. Kansas City, Mo: American Academy of Family Physicians, 1998. Monograph 234. Petrie K, Frey KA, editors. Preconception Care/Infertility. Kansas City, Mo: American Academy of Family Physicians, 1998. Monograph 234.
90.
go back to reference Spring B, Pagoto S, Pingitore R, Doran N, Schneider K, Hedeker D. Randomized controlled trial for behavioral smoking and weight control treatment: effect of concurrent versus sequential intervention. J Consult Clin Psychol 2004;72:785–96.PubMedCrossRef Spring B, Pagoto S, Pingitore R, Doran N, Schneider K, Hedeker D. Randomized controlled trial for behavioral smoking and weight control treatment: effect of concurrent versus sequential intervention. J Consult Clin Psychol 2004;72:785–96.PubMedCrossRef
Metadata
Title
Preconception Care for Improving Perinatal Outcomes: The Time to Act
Authors
Hani K. Atrash
Kay Johnson
Myron (Mike) Adams
José F. Cordero
Jennifer Howse
Publication date
01-09-2006
Publisher
Springer US
Published in
Maternal and Child Health Journal / Issue Special Issue 1/2006
Print ISSN: 1092-7875
Electronic ISSN: 1573-6628
DOI
https://doi.org/10.1007/s10995-006-0100-4

Other articles of this Special Issue 1/2006

Maternal and Child Health Journal 1/2006 Go to the issue